Altimmune, Inc.

ALT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 5, 2026
4 Oct 5, 2026
4 Oct 2, 2026
3 Oct 2, 2026
8-K Sep 29, 2026 8-K
4 Sep 17, 2026
4 Aug 13, 2026
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 8-K
4 Aug 3, 2026
4 Aug 3, 2026
8-K Jul 28, 2026 8-K
8-K Jun 16, 2026 FORM 8-K
SCHEDULE 13G/A May 15, 2026
S-8 May 13, 2026 S-8
10-Q May 13, 2026 10-Q
8-K May 13, 2026 8-K
SCHEDULE 13G May 12, 2026
SCHEDULE 13G May 1, 2026
SCHEDULE 13G May 1, 2026
4 May 1, 2026
4 May 1, 2026
4 May 1, 2026
4 May 1, 2026
4 May 1, 2026
← Newer Page 1 of 59 · 1458 filings Older →